Shade Olatunde Selected Research

Secondary Prevention

12/2006

Trial of Essiac to ascertain its effect in women with breast cancer (TEA-BC).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shade Olatunde Research Topics

Disease

1	Hemophilia A (Haemophilia) 01/2021
1	Fatigue 12/2006
1	Neoplasms (Cancer) 12/2006
1	Breast Neoplasms (Breast Cancer) 12/2006

Drug/Important Bio-Agent (IBA)

1	emicizumabIBA 01/2021
1	Factor VIII (Coagulation Factor VIII)IBA 01/2021
1	TeaIBA 12/2006
1	EssiacIBA 12/2006

Therapy/Procedure

2	Therapeutics 01/2021 - 12/2006
1	Secondary Prevention 12/2006